Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
792 Natural killer T cell immunotherapy combined with fusogenic oncolytic virus and PD-1 blockade enhances survival in a mouse model of spontaneous lung adenocarcinomaLukacs, JordanJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A825-A825 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
2 |
Material Type: Ata de Congresso
|
455 Fostrox (MIV-818) in combination with anti-PD-1 shows increased efficacy in nonclinical tumor models in vivoOberg, Fredrik ; Bhoi, Sujata ; Jensen, Malene ; Morris, Tom ; Tunblad, Karin ; Wallberg, HansJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A475-A475 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
3 |
Material Type: Ata de Congresso
|
Smart Agriculture Land Crop Protection Intrusion Detection Using Artificial IntelligenceS, Kiruthika ; P, Sakthi ; K, Sanjay ; N, Vikraman ; T, Premkumar ; R, Yoganantham ; M, Raja Senthil Kumar, T.S. ; Vijayan, V.E3S Web of Conferences, 2023, Vol.399, p.4006 [Periódico revisado por pares]Les Ulis: EDP SciencesTexto completo disponível |
|
4 |
Material Type: Ata de Congresso
|
1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumorsSalek-Ardakani, Shahram ; DiRaimondo, Thomas ; Budimir, Natalija ; Ma, Lina ; Shenhav, Simon ; Cicchini, Vanessa ; Wu, Hua ; Jocic, Renee ; Roup, Fabrece ; Cambell, Calvin ; Caffaro, Carolina ; Aerni, Hans ; Eskiocak, Ugur ; Godfrey, Wayne ; Winter, Charles ; Nasoff, Marc ; Gibson, Neil ; Campbell, DavidJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1167-A1167 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
5 |
Material Type: Ata de Congresso
|
Crop protection from animals based on machine learningP, Marichamy ; P, Karuppasamy ; B, Heera ; R, Leena Keresi ; M, Kanagalakshmi Senthil Kumar, T.S. ; Vijayan, V.E3S Web of Conferences, 2023, Vol.399, p.4018 [Periódico revisado por pares]Les Ulis: EDP SciencesTexto completo disponível |
|
6 |
Material Type: Ata de Congresso
|
Dairy goat breeding in Russia and the world (review)Miroshina, Tatyana ; Chalova, Natalya Shergaziev, U.A. ; Laamarti, Y.A.E3S Web of Conferences, 2023, Vol.380, p.1004 [Periódico revisado por pares]Les Ulis: EDP SciencesTexto completo disponível |
|
7 |
Material Type: Ata de Congresso
|
505 High-dimensional analyses of intratumoral myeloid cells highlights presence of distinct myeloid cell phenotypes in immune checkpoint-sensitive and resistant tumorsAnandhan, Swetha ; Goswami, Sangeeta ; Herbrich, Shelley ; Chen, Yulong ; Sharma, PadmaneeJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A528-A528 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
8 |
Material Type: Ata de Congresso
|
211 Chemical priming of natural killer cells for cancer immunotherapyChoi, Seung Hee ; Eun-Su, Ko ; Joo Dong Park ; Kyung-Soon ParkJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A225-A225 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
9 |
Material Type: Ata de Congresso
|
449 Cyclic disruption of the mitogen-activated protein kinase (MAPK) pathway by the dual MEK inhibitor, IMM-6-415, enhances PD1 and CTLA4 checkpoint blockade in RAS mutant tumorsHall, Brett ; Travesa, Anna ; Yamamura, Amy ; Axel, Amy ; Kolitz, Sarah ; Funt, Jason ; Fowler, Kevin ; Nord, Matthew ; Nair, Praveen ; Barrett, Scott ; Zeskind, Benjamin ; King, PeterJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A469-A469 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
10 |
Material Type: Ata de Congresso
|
1106 HZ-S506, a selective and orally bioavailable HPK1 degrader, is efficacious as a single agent or in combination with PD-1 antibodyWu, Yizhe ; Zhou, Xinglu ; Jin, Tingting ; Jin, XinxinJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1149-A1149 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |